Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Prognostic Accuracy of Three-Dimensional Echocardiography in Patients With Pre-Capillary Pulmonary Hypertension. | Pulm Circ | 2026 | 41766755 | PubTator, text mining | PubMed |
| Percutaneous retroperitoneal splenorenal shunt creation after failed PVR-TIPS attempt. | CVIR Endovasc | 2026 | 41762382 | PubTator, text mining | PubMed |
| Epigenetic Drivers of Pulmonary Hypertension: Environment Meets Genome. | Cureus | 2026 | 41756345 | PubTator, text mining | PubMed |
| Reprogramming tumor immunity through APOBEC3s-mediated mutagenesis: from genome instability to immune checkpoint interactions. | Front Immunol | 2026 | 41756300 | PubTator, text mining | PubMed |
| Combination of oncolytic viruses and immune checkpoint inhibitors for treatment of high-grade gliomas. | Front Neurol | 2026 | 41756179 | PubTator, text mining | PubMed |
| A Prediction Model for Uncoating Receptor Usage in Human Enteroviruses Based on Amino Acid Sequences and a Naive Bayes Algorithm. | Viruses | 2026 | 41754579 | PubTator, text mining | PubMed |
| Bench-to-Bedside Insights into the Challenges of Immunosuppression in Sepsis. | Pathogens | 2026 | 41754412 | PubTator, text mining | PubMed |
| Natural Killer Cell Phenotype and Function as a Predictive Factor for Treatment Response to Neoadjuvant Therapy in Breast Cancer Patients. | Int J Mol Sci | 2026 | 41751774 | PubTator, text mining | PubMed |
| Integrated Weighted Gene Co-Expression Network and Single-Cell RNA Sequencing Analyses Reveal the Prognostic Significance of Hypoxia in Gastric Cancer. | Biomedicines | 2026 | 41751324 | PubTator, text mining | PubMed |
| Transcutaneous Carbon Dioxide Therapy Significantly Accelerates Diabetic Foot Ulcer Healing: A Multicentre Randomised Controlled Trial. | Biomedicines | 2026 | 41751321 | PubTator, text mining | PubMed |
| From Bench to Bedside: Advancements in Precision Oncology and Drug Discovery for Osteosarcoma. | Cancers (Basel) | 2026 | 41749815 | PubTator, text mining | PubMed |
| Physiology-Based Diagnosis and Management of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension (BPD-PH). | Children (Basel) | 2026 | 41749628 | PubTator, text mining | PubMed |
| Functionalized Biomaterials in the Investigation of the Effects of Fluid Shear Forces in the Immune Regulation of Cancer Progression and Metastasis. | J Funct Biomater | 2026 | 41745543 | PubTator, text mining | PubMed |
| The Role of CD4+ T Helper Cell Subsets in Hepatocellular Carcinoma: Implications for Tumour Progression and Immunotherapy. | Cells | 2026 | 41744794 | PubTator, text mining | PubMed |
| MicroRNA-15a-5p suppresses triple-negative breast cancer cell proliferation and invasion by modulating T-cell immunoreceptor associated with immunoglobulin and ITIM domain expression. | Cytojournal | 2026 | 41743753 | PubTator, text mining | PubMed |
| PhIP-Seq: unveiling the complexity of antibody repertoires in health and disease. | Front Immunol | 2026 | 41743708 | PubTator, text mining | PubMed |
| From fibrotic mechanisms to clinical translation: the drug therapy revolution and delivery system breakthrough in proliferative vitreoretinopathy. | Front Immunol | 2026 | 41743704 | PubTator, text mining | PubMed |
| Preclinical exploration and current clinical applications of immunotherapeutic strategies for hepatocellular carcinoma. | Front Immunol | 2026 | 41743701 | PubTator, text mining | PubMed |
| Identification of potential ferroptosis-related biomarkers in proliferative vitreoretinopathy based on machine learning. | Front Mol Biosci | 2026 | 41743358 | PubTator, text mining | PubMed |
| Nanotechnology-Driven Precision Modulation of Transplant Immunity: From Mechanistic Insights to Clinical Tolerance. | Int J Nanomedicine | 2026 | 41743232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=6